• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
73,983.18 64.42
( 0.09%)
Global Indices
Nasdaq
50,884.98 77.97
(0.15%)
Dow Jones
7,407.31 -19.42
(-0.26%)
Hang Seng
64,234.22 -1,182.41
(-1.81%)
Nikkei 225
10,242.24 -130.96
(-1.26%)
Forex
USD-INR
95.53 0.30
(0.32%)
EUR-INR
110.14 0.47
(0.43%)
GBP-INR
127.43 0.45
(0.36%)
JPY-INR
0.60 0.00
(0.41%)

EQUITY - MARKET SCREENER

Zim Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
541400
INE518E01015
53.0292332
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ZIMLAB
132.44
581.54
EPS(TTM)
Face Value()
Div & Yield %
0.82
10
0
 

Nakoda Group of Industries reports standalone net profit of Rs 0.74 crore in the March 2026 quarter
May 02,2026
Net profit of Nakoda Group of Industries reported to Rs 0.74 crore in the quarter ended March 2026 as against net loss of Rs 2.44 crore during the previous quarter ended March 2025. Sales declined 20.60% to Rs 11.10 crore in the quarter ended March 2026 as against Rs 13.98 crore during the previous quarter ended March 2025.

For the full year,net profit reported to Rs 1.50 crore in the year ended March 2026 as against net loss of Rs 3.64 crore during the previous year ended March 2025. Sales declined 6.03% to Rs 43.46 crore in the year ended March 2026 as against Rs 46.25 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales11.1013.98 -21 43.4646.25 -6
OPM %16.49-17.45 -11.00-4.30 -
PBDT1.46-2.99 LP 3.44-3.68 LP
PBT1.10-3.27 LP 2.12-4.86 LP
NP0.74-2.44 LP 1.50-3.64 LP